Rochester, NY 9/4/2009 7:12:08 PM
HEB Hemispherx Biopharma, Inc. Market Stocks Stands High
HEB Hemispherx Biopharma, Inc.
Traders love momo stocks like HEB and today Hemispherx BioPharma is piquing traders' interest. HEB has always been a fast moving stock that has ranged from a low of $0.25 to a high of $4.54 during the past 52-weeks, so tread lightly with this one.
Last Trade: 2.01
Day's Range: 0.25 - 4.54
Trade Time: Sep 3
52wk Range: 0.00 - 4.54
Change: 0.00 (0.00%)
Volume: 0
Prev Close: 2.01
Avg Vol (3m): 9,853,500
Open: N/A
Market Cap: 253.74M
StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
ABOUT Hemispherx Biopharma
Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development, manufacture, marketing, and distribution of new drug therapies for the treatment of viral and immune based chronic disorders. The company's products include Alferon N Injection for the treatment of genital warts; and Ampligen, an experimental drug that is in human clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, HIV, renal cell carcinoma, and malignant melanoma. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and viral diseases, which is in the early stage of development; and Oragens for the treatment of viral diseases and disorders of the immune system. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll down this page or visit our site to join our free newsletter and begin receiving daily stock alerts.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
